These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1772 related items for PubMed ID: 16856112

  • 1. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK, McDonald JW.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD006097. PubMed ID: 16856112
    [Abstract] [Full Text] [Related]

  • 2. Natalizumab for induction of remission in Crohn's disease.
    MacDonald JK, McDonald JW.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD006097. PubMed ID: 17253580
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW, Feagan BG, Jewell D, Brynskov J, Stange EF, Macdonald JK.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD000297. PubMed ID: 15846602
    [Abstract] [Full Text] [Related]

  • 4. Natalizumab for induction of remission in Crohn's disease.
    Nelson SM, Nguyen TM, McDonald JW, MacDonald JK.
    Cochrane Database Syst Rev; 2018 Aug 01; 8(8):CD006097. PubMed ID: 30068022
    [Abstract] [Full Text] [Related]

  • 5. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R, Preiss JC, MacDonald JK, Timmer A.
    Cochrane Database Syst Rev; 2015 May 05; (5):CD007572. PubMed ID: 25942580
    [Abstract] [Full Text] [Related]

  • 6. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D, Macdonald JK, Chande N.
    Cochrane Database Syst Rev; 2014 Feb 21; (2):CD010410. PubMed ID: 24558033
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW, Bickston SJ.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD006893. PubMed ID: 18254120
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Wang Y, Tsoulis DJ, MacDonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2014 Aug 06; 2014(8):CD003459. PubMed ID: 25099640
    [Abstract] [Full Text] [Related]

  • 10. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    MacDonald JK, Nguyen TM, Khanna R, Timmer A.
    Cochrane Database Syst Rev; 2016 Nov 25; 11(11):CD007572. PubMed ID: 27885650
    [Abstract] [Full Text] [Related]

  • 11. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Wang Y, MacDonald JK, Hanauer S.
    Cochrane Database Syst Rev; 2016 Jul 03; 7(7):CD008870. PubMed ID: 27372735
    [Abstract] [Full Text] [Related]

  • 12. Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody.
    Drugs R D; 2004 Jul 03; 5(2):102-7. PubMed ID: 15293871
    [Abstract] [Full Text] [Related]

  • 13. Low dose naltrexone for induction of remission in Crohn's disease.
    Parker CE, Nguyen TM, Segal D, MacDonald JK, Chande N.
    Cochrane Database Syst Rev; 2018 Apr 01; 4(4):CD010410. PubMed ID: 29607497
    [Abstract] [Full Text] [Related]

  • 14. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M, Taylor K, Akobeng AK, Thomas AG.
    Cochrane Database Syst Rev; 2014 Aug 01; 2014(8):CD010233. PubMed ID: 25081347
    [Abstract] [Full Text] [Related]

  • 15. Natalizumab for relapsing remitting multiple sclerosis.
    Pucci E, Giuliani G, Solari A, Simi S, Minozzi S, Di Pietrantonj C, Galea I.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007621. PubMed ID: 21975773
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cannabis for the treatment of Crohn's disease.
    Kafil TS, Nguyen TM, MacDonald JK, Chande N.
    Cochrane Database Syst Rev; 2018 Nov 08; 11(11):CD012853. PubMed ID: 30407616
    [Abstract] [Full Text] [Related]

  • 18. Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease.
    Ko HH, Bressler B.
    Expert Rev Gastroenterol Hepatol; 2007 Oct 08; 1(1):29-39. PubMed ID: 19072431
    [Abstract] [Full Text] [Related]

  • 19. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Hanauer S.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008870. PubMed ID: 21154400
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 89.